Does neuroimaging have a role in predicting outcomes in psychosis?
作者信息
McGuire Philip, Dazzan Paola
机构信息
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.
出版信息
World Psychiatry. 2017 Jun;16(2):209-210. doi: 10.1002/wps.20426.
Abstract
摘要
相似文献
1
Does neuroimaging have a role in predicting outcomes in psychosis?神经影像学在预测精神病的预后方面是否有作用？
World Psychiatry. 2017 Jun;16(2):209-210. doi: 10.1002/wps.20426.
2
Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion.对临床高危青年精神病患者神经影像学研究结果的选择性综述：迈向转化生物标志物之路
Front Psychiatry. 2020 Sep 23;11:567534. doi: 10.3389/fpsyt.2020.567534. eCollection 2020.
3
The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review.外周炎症在精神病临床结局及脑影像学异常中的作用：一项系统综述
Front Psychiatry. 2021 Feb 19;12:612471. doi: 10.3389/fpsyt.2021.612471. eCollection 2021.
4
Structural neuroimaging in psychosis: a systematic review and economic evaluation.精神病中的结构神经影像学：系统评价与经济学评估
Health Technol Assess. 2008 May;12(18):iii-iv, ix-163. doi: 10.3310/hta12180.
5
Prediction of transition to psychosis from an at-risk mental state using structural neuroimaging, genetic, and environmental data.利用结构神经影像学、基因和环境数据预测处于精神病风险状态者向精神病的转变。
Front Psychiatry. 2023 Jan 19;13:1086038. doi: 10.3389/fpsyt.2022.1086038. eCollection 2022.
6
Retrospective study on structural neuroimaging in first-episode psychosis.首发精神病结构性神经影像学回顾性研究
PeerJ. 2016 May 26;4:e2069. doi: 10.7717/peerj.2069. eCollection 2016.
7
Neuroimaging Markers of Resiliency in Youth at Clinical High Risk for Psychosis: A Qualitative Review.神经影像学标志物在精神病临床高风险青年中的韧性研究：一项定性综述。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Feb;6(2):166-177. doi: 10.1016/j.bpsc.2020.06.002. Epub 2020 Jun 10.
8
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice.迈向精神病精准医学：多模态多中心研究的优势与挑战——PSYSCAN：将神经影像学研究发现转化为临床实践。
Schizophr Bull. 2020 Feb 26;46(2):432-441. doi: 10.1093/schbul/sbz067.
9
Structural neuroimaging across early-stage psychosis: Aberrations in neurobiological trajectories and implications for the staging model.早期精神病的结构神经影像学：神经生物学轨迹异常及其对分期模型的影响。
Aust N Z J Psychiatry. 2017 May;51(5):455-476. doi: 10.1177/0004867416670522. Epub 2016 Oct 12.
10
Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis.精神病患者的行为、临床和多模态影像学表型的多变量关联。
JAMA Psychiatry. 2018 Apr 1;75(4):386-395. doi: 10.1001/jamapsychiatry.2017.4741.
引用本文的文献
1
Dissociation between neuroanatomical and symptomatic subtypes in schizophrenia.精神分裂症的神经解剖亚型和症状亚型的分离。
Eur Psychiatry. 2023 Sep 13;66(1):e78. doi: 10.1192/j.eurpsy.2023.2446.
2
Predicting treatment resistance from first-episode psychosis using routinely collected clinical information.利用常规收集的临床信息预测首发精神病的治疗耐药性。
Nat Ment Health. 2023 Jan 19;1(1):25-35. doi: 10.1038/s44220-022-00001-z.
3
Markers of Schizophrenia-A Critical Narrative Update.精神分裂症的标志物——批判性叙述更新
J Clin Med. 2022 Jul 7;11(14):3964. doi: 10.3390/jcm11143964.
4
Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.多模态预测处于精神病发病风险增加的个体的阴性症状严重程度。
Transl Psychiatry. 2021 May 24;11(1):312. doi: 10.1038/s41398-021-01409-4.
5
Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study.精神病首次临床发作时的症状缓解与大脑皮质网络：OPTiMiSE 研究。
Schizophr Bull. 2021 Mar 16;47(2):444-455. doi: 10.1093/schbul/sbaa115.
6
Neuroimaging in Schizophrenia.精神分裂症的神经影像学研究。
Neuroimaging Clin N Am. 2020 Feb;30(1):73-83. doi: 10.1016/j.nic.2019.09.007. Epub 2019 Nov 11.
7
Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies.预测治疗抵抗性精神分裂症的因素：前瞻性观察研究的系统综述。
Psychol Med. 2021 Jan;51(1):44-53. doi: 10.1017/S0033291719002083. Epub 2019 Aug 29.
8
Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders.抗精神病药物在精神障碍的诊断、预后和预测中的作用。
Schizophr Bull. 2019 Jan 1;45(1):233-246. doi: 10.1093/schbul/sby021.
本文引用的文献
1
Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research.磁共振成像与首发精神分裂症的预后预测：当前证据综述及未来研究方向
Schizophr Bull. 2015 May;41(3):574-83. doi: 10.1093/schbul/sbv024. Epub 2015 Mar 23.
2
White matter integrity as a predictor of response to treatment in first episode psychosis.白质完整性作为首发精神病治疗反应的预测指标。
Brain. 2014 Jan;137(Pt 1):172-82. doi: 10.1093/brain/awt310. Epub 2013 Nov 19.
3
Cortical folding defects as markers of poor treatment response in first-episode psychosis.皮质折叠缺陷可作为首发精神病治疗反应不良的标志物。
JAMA Psychiatry. 2013 Oct;70(10):1031-40. doi: 10.1001/jamapsychiatry.2013.203.
4
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.精神分裂症中抗精神病药物治疗抵抗与谷氨酸水平升高但多巴胺功能正常有关。
Biol Psychiatry. 2014 Mar 1;75(5):e11-3. doi: 10.1016/j.biopsych.2013.06.011. Epub 2013 Jul 25.
5
Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes.首发精神病后双侧海马体积增加与良好的临床、功能和认知结局相关。
Psychol Med. 2014 Apr;44(6):1279-91. doi: 10.1017/S0033291713001712. Epub 2013 Jul 18.
6
Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study.首发精神病性 episode 疾病进程的个体化预测：支持向量机 MRI 研究。
Psychol Med. 2012 May;42(5):1037-47. doi: 10.1017/S0033291711002005. Epub 2011 Nov 7.
7
Power calculations for multicenter imaging studies controlled by the false discovery rate.多中心影像研究的功效计算，通过假发现率进行控制。
Hum Brain Mapp. 2010 Aug;31(8):1183-95. doi: 10.1002/hbm.20927.
8
Assessment of the increase in variability when combining volumetric data from different scanners.合并来自不同扫描仪的容积数据时变异性增加的评估。
Hum Brain Mapp. 2009 Feb;30(2):355-68. doi: 10.1002/hbm.20511.
9
Brain volume changes in the first year of illness and 5-year outcome of schizophrenia.精神分裂症发病第一年的脑容量变化及5年预后
Br J Psychiatry. 2006 Oct;189:381-2. doi: 10.1192/bjp.bp.105.015701.
10
Biological determinants of difficult to treat patients with schizophrenia.精神分裂症难治性患者的生物学决定因素。
Br J Psychiatry Suppl. 1996 Dec(31):5-9.
Zotero 插件